Back to the main directory
EarningsReview / Equity
- Zhongsheng Group Holdings (881 HK) by HSBC
- FLSmidth & Co - Digging it by Danske Bank Equity Research
- While Q1 should be the growth bottom, demand remains muted by BNP Paribas Exane
- ESG pays again by BNP Paribas Exane
- Q2 expenses great, forward outlook more concerning by BNP Paribas Exane
- See the Forest through the Trees by BNP Paribas Exane
- BNPP Exane ESG Conference by BNP Paribas Exane
- Is India your Plus One? by BNP Paribas Exane
- Danieli - THE GREEN STEEL REVOLUTION IS HERE TO STAY by Equita Sim
- INVEST SECURITIES – BIOPHYTIS : Bonne maitrise des coûts, disponibilités confortables - NEUTRE, OC 0,04€ by Invest Securities
- Wedia - Marge d’EBITDA proche de 13%, un peu inférieure à nos attentes - ajustement de nos perspectives by MidCap Partners
- Gentili Mosconi - Mix optimisé ! by MidCap Partners
- Virbac - Défend plutôt bien sa marge au S1 mais maintient ses perspectives annuelles by MidCap Partners
- Kerlink - Bientôt, peut-être, le bout du tunnel ! by MidCap Partners
- Ateme - Résultats semestriels by MidCap Partners
- 2023 CMD: Focus on capacity and costs by BNP Paribas Exane
- Ateme - Half-Year Results by MidCap Partners
- OSAI AS - Margins Under Pressure by MidCap Partners
- Expert.ai - Cost Reductions by MidCap Partners
- Xilam - Increase Fixed Costs & Accounting Implications of Model Change by MidCap Partners
- Virbac - Margins Well Defended in H1, FY Outlook Reiterated by MidCap Partners
- OPDENERGY - Uneventful 2Q23 results; price is driven by offer; Neutral by JB Capital Markets
- Shield Therapeutics - Ramped up and heading into a stronger H223 by Edison Investment Research
- Hilton Food Group Plc (HFG LN) by HSBC
- A. P. Moller - Maersk - Downcycle to persist until H1 24, but priced in by Danske Bank Equity Research